These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans. Backeljauw PF; Chernausek SD Horm Res; 2006; 65 Suppl 1():21-7. PubMed ID: 16508330 [No Abstract] [Full Text] [Related]
7. The role of recombinant human insulin-like growth factor-I in treating children with short stature. Collett-Solberg PF; Misra M; J Clin Endocrinol Metab; 2008 Jan; 93(1):10-8. PubMed ID: 18165284 [TBL] [Abstract][Full Text] [Related]
8. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial. Midyett LK; Rogol AD; Van Meter QL; Frane J; Bright GM; J Clin Endocrinol Metab; 2010 Feb; 95(2):611-9. PubMed ID: 19880790 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of insulin-like growth factor-1 in Indian growth hormone-deficient children on growth hormone therapy. Ekbote VH; Rustagi VT; Khadilkar VV; Khadilkar AV; Chiplonkar SA Endocr Res; 2011; 36(3):109-15. PubMed ID: 21736493 [TBL] [Abstract][Full Text] [Related]
11. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572 [TBL] [Abstract][Full Text] [Related]
12. A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients. Petriczko E; Wikiera B; Horodnicka-Józwa A; Marcinkiewicz K; Szmit-Domagalska J; Kędzia A; Durzyńska J; Broniarczyk J; Gabryelczyk B; Noczyńska A; Walczak M Pediatr Endocrinol Diabetes Metab; 2011; 17(4):233-8. PubMed ID: 22248785 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF)-I gene deletion. Camacho-Hübner C; Woods KA; Clark AJ; Savage MO Rev Endocr Metab Disord; 2002 Dec; 3(4):357-61. PubMed ID: 12424437 [No Abstract] [Full Text] [Related]
15. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations. Clark RG Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options? Rosenbloom AL J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604 [No Abstract] [Full Text] [Related]
17. [Therapentic efficacy of recombinant human growth hormone in postpuberal children with idiopathic short stature]. Luo JM; He YQ; Liu M Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):208-10. PubMed ID: 24568920 [No Abstract] [Full Text] [Related]
18. Treatment with Recombinant Human Insulin-Like Growth Factor-1 in Severe Primary IGF Deficiency and Beyond. Ranke MB Horm Res Paediatr; 2015; 83(5):358-60. PubMed ID: 25871890 [No Abstract] [Full Text] [Related]
19. Recombinant human IGF-1 (insulin-like growth factor) therapy: where do we stand today? Balhara B; Misra M; Levitsky LL Indian J Pediatr; 2012 Feb; 79(2):244-9. PubMed ID: 22090255 [TBL] [Abstract][Full Text] [Related]
20. The role of recombinant insulin-like growth factor I in the treatment of the short child. Rosenbloom AL Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]